Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.
Answered by Will Quince
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to reform the NHS pathway for procurement of innovative medical technology; and when he expects the pathway to deliver timely access to medical technology.
Answered by Will Quince
The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.
The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.
The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:
https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap
The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.
The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.
The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.
The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:
We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to innovative medical technologies through the NHS.
Answered by Will Quince
The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.
The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.
The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:
https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap
The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.
The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.
The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.
The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:
We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the adoption of innovative medical technologies by the NHS.
Answered by Will Quince
The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.
The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.
The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:
https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap
The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.
The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.
The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.
The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:
We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of innovative medical technologies on the (a) Life Sciences Vision and (b) MedTech Strategy.
Answered by Will Quince
The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.
The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.
The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:
https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap
The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.
The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.
The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.
The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:
We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.
Asked by: Mark Eastwood (Conservative - Dewsbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress has been made towards ensuring that persons needing care should not be forced to sell their home to pay for it.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
We are committed to bringing forward a proposal for social care this year to ensure that everyone is treated with dignity and respect and to find long term solutions for one of the biggest challenges we face as a society. The reform of social care and its funding arrangements are complex areas and a range of options are being considered.